LRRK2 mutations are not common in Alzheimer's disease

Mechanisms of Ageing and Development

Volumn 126, Issue 11, 2005, Pages 1201-1205

  Toft, Mathias ^a,b   Sando, Sigrid Botne ^b   Melquist, Stacey ^a   Ross, Owen A ^a   White, Linda R ^b   Aasly, Jan O ^c   Farrer, Matthew J ^a  

^a MAYO CLINIC   (United States)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Alzheimer's disease; Dementia; Genetics; LRRK2

Indexed keywords

LEUCINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME; CHROMOSOME 12; DEMENTIA; EVOLUTIONARY ADAPTATION; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES;

EID: 25144468286     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2005.06.010     Document Type: Article

References (25)

1. J.O. Aasly, M. Toft, I. Fernandez-Mata, J. Kachergus, M. Hulihan, L.R. White, and M. Farrer Clinical features of LRRK2-associated Parkinson's disease in central Norway Ann. Neurol. 57 2005 762 765
2. H. Brodaty, and C.M. Moore The Clock Drawing Test for dementia of the Alzheimer's type: a comparison of three scoring methods in a memory disorders clinic Int. J. Geriatr. Psychiatry 12 1997 619 627
3. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
4. A. Di Fonzo, C.F. Rohe, J. Ferreira, H.F. Chien, L. Vacca, F. Stocchi, L. Guedes, E. Fabrizio, M. Manfredi, N. Vanacore, S. Goldwurm, G. Breedveld, C. Sampaio, G. Meco, E. Barbosa, B.A. Oostra, V. Bonifati Italian Parkinson Genetics Network A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 365 2005 412 415
5. M.S. Forman, J.Q. Trojanowski, and V.M. Lee Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs Nat. Med. 10 2005 1055 1063
6. W.P. Gilks, P.M. Abou-Sleiman, S. Gandhi, S. Jain, A. Singleton, A.J. Lees, K. Shaw, K.P. Bhatia, V. Bonifati, N.P. Quinn, J. Lynch, D.G. Healy, J.L. Holton, T. Revesz, and N.W. Wood A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 2005 415 416
7. A.F. Jorm, and P.A. Jacomb The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms Psychol. Med. 19 1989 1015 1022
8. J. Kachergus, I.F. Mata, M. Hulihan, J.P. Taylor, S. Lincoln, J. Aasly, J.M. Gibson, O.A. Ross, T. Lynch, J. Wiley, H. Payami, J. Nutt, D.M. Maraganore, K. Czyzewski, M. Styczynska, Z.K. Wszolek, M.J. Farrer, and M. Toft Identification of a novel LRRK2 mutation linked to autosomal dominant Parkinsonism: evidence of a common founder across European populations Am. J. Hum. Genet. 76 2005 672 680
9. K.M. Langa, N.L. Foster, and E.B. Larson Mixed dementia: emerging concepts and therapeutic implications JAMA 292 2004 2901 2908
10. O.L. Lopez, J.T. Becker, W. Klunk, J. Saxton, R.L. Hamilton, D.I. Kaufer, R.A. Sweet, C. Cidis Meltzer, S. Wisniewski, M.I. Kamboh, and S.T. DeKosky Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I Neurology 55 2000 1854 1862
11. I. McKeith, J. Mintzer, D. Aarsland, D. Burn, H. Chiu, J. Cohen-Mansfield, D. Dickson, B. Dubois, J.E. Duda, H. Feldman, S. Gauthier, G. Halliday, B. Lawlor, C. Lippa, O.L. Lopez, J. Carlos Machado, J. O'Brien, J. Playfer, and W. Reid Dementia with Lewy bodies Lancet Neurol. 3 2004 19 28
12. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, D.P. Salmon, J. Lowe, S.S. Mirra, E.J. Byrne, G. Lennox, N.P. Quinn, J.A. Edwardson, P.G. Ince, C. Bergeron, A. Burns, B.L. Miller, S. Lovestone, D. Collerton, E.N. Jansen, C. Ballard, R.A. de Vos, G.K. Wilcock, K.A. Jellinger, and R.H. Perry Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
13. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
14. S.A. Montgomery, and M. Åsberg A new depression scale designed to be sensitive to change Br. J. Psychiatry 134 1979 382 389
15. A.J. Myers, and A.M. Goate The genetics of late-onset Alzheimer's disease Curr. Opin. Neurol. 14 2001 433 440
16. W.C. Nichols, N. Pankratz, D. Hernandez, C. Paisan-Ruiz, S. Jain, C.A. Halter, V.E. Michaels, T. Reed, A. Rudolph, C.W. Shults, A. Singleton, and T. Foroud Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease Lancet 365 2005 410 412
17. C. Paisan-Ruiz, S. Jain, E.W. Evans, W.P. Gilks, J. Simon, M. van der Brug, A.L. de Munain, S. Aparicio, A.M. Gil, N. Khan, J. Johnson, J.R. Martinez, D. Nicholl, I.M. Carrera, A.S. Pena, R. de Silva, A. Lees, J.F. Marti-Masso, J. Perez-Tur, N.W. Wood, and A.B. Singleton Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600
18. M.A. Pericak-Vance, M.P. Bass, L.H. Yamaoka, P.C. Gaskell, W.K. Scott, H.A. Terwedow, M.M. Menold, P.M. Conneally, G.W. Small, J.M. Vance, A.M. Saunders, A.D. Roses, and J.L. Haines Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12 JAMA 278 1997 1237 1241
19. C.A. Ross, and M.A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 10 Suppl. 2004 10 17
20. W.K. Scott, J.M. Grubber, P.M. Conneally, G.W. Small, C.M. Hulette, C.K. Rosenberg, A.M. Saunders, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity Am. J. Hum. Genet. 66 2000 922 932
21. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
22. The Lund and Manchester Groups Clinical and neuropathological criteria for frontotemporal dementia J. Neurol. Neurosurg. Psychiatry 57 1994 416 418
23. M. Toft, I.F. Mata, J.M. Kachergus, O.A. Ross, and M.J. Farrer LRRK2 mutations and Parkinsonism Lancet 365 2005 1229 1230
24. Z.K. Wszolek, P. Vieregge, R.J. Uitti, T. Gasser, O. Yasuhara, P. McGeer, K. Berry, D.B. Calne, Vingerhoets FJG, C. Klein, and R.F. Pfeiffer German-Canadian family (family A) with Parkinsonism, amyotrophy, and dementia: longitudinal observations Parkinsonism Relat. Disord. 3 1997 125 139
25. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, S. Lincoln, J. Kachergus, M. Hulihan, R.J. Uitti, D.B. Calne, A.J. Stoessl, R.F. Pfeiffer, N. Patenge, I.C. Carbajal, P. Vieregge, F. Asmus, B. Muller-Myhsok, D.W. Dickson, T. Meitinger, T.M. Strom, Z.K. Wszolek, and T. Gasser Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology Neuron 44 2004 601 607